Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-28

FDA Approved: LUMIFY REDNESS RELIEVER EYE DROPS — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

The FDA approved a supplemental NDA for LUMIFY redness reliever eye drops (brimonidine tartrate) from Bausch & Lomb, enabling continued marketing with updated l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUMIFY REDNESS RELIEVER EYE DROPS (Brimonidine tartrate)

Snippet

SUPPL AP for LUMIFY REDNESS RELIEVER EYE DROPS (BRIMONIDINE TARTRATE)